Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Science Center, 1901 Perdido Street, New Orleans, LA 70112, USA.
Cardiovasc Res. 2010 Jul 1;87(1):111-8. doi: 10.1093/cvr/cvq043. Epub 2010 Feb 5.
Our aim was to test the hypothesis that the repeated, binge administration of methamphetamine would produce oxidative stress in the myocardium leading to structural remodeling and impaired left ventricular function.
Echocardiography and Millar pressure-volume catheters were used to monitor left ventricular structure and function in rats subjected to four methamphetamine binges (3 mg/kg, iv for 4 days, separated by a 10-day drug-free period). Hearts from treated and control rats were used for histological or proteomic analysis. When compared with saline treatment, four methamphetamine binges produced eccentric left ventricular hypertrophy. The drug also significantly impaired systolic function (decreased fractional shortening, ejection fraction, and adjusted maximal power) and produced significant diastolic dysfunction (increased -dP/dt and tau). Dihydroethedium staining showed that methamphetamine significantly increased (285%) the levels of reactive oxygen species in the left ventricle. Treatment with methamphetamine also resulted in the tyrosine nitration of myofilament (desmin, myosin light chain) and mitochondrial (ATP synthase, NADH dehydrogenase, cytochrome c oxidase, prohibitin) proteins. Treatment with the superoxide dismutase mimetic, tempol in the drinking water prevented methamphetamine-induced left ventricular dilation and systolic dysfunction; however, tempol (2.5 mM) did not prevent the diastolic dysfunction. Tempol significantly reduced, but did not eliminate dihydroethedium staining in the left ventricle, nor did it prevent the tyrosine nitration of mitochondrial and contractile proteins.
This study shows that oxidative stress plays a significant role in mediating methamphetamine-induced eccentric left ventricular dilation and systolic dysfunction.
我们旨在验证以下假设,即重复、 binge 给予安非他命会导致心肌氧化应激,从而导致结构重塑和左心室功能受损。
超声心动图和 Millar 压力-容积导管用于监测接受 4 次安非他命 binge(3mg/kg,iv 持续 4 天,间隔 10 天无药期)的大鼠的左心室结构和功能。用处理过和对照大鼠的心脏进行组织学或蛋白质组学分析。与生理盐水处理相比,4 次安非他命 binge 导致左心室偏心性肥厚。该药物还显著损害收缩功能(缩短分数、射血分数和调整后的最大功率降低)并产生明显的舒张功能障碍(-dP/dt 和 tau 增加)。二氢乙啶染色显示,安非他命显著增加了左心室中活性氧(ROS)的水平(增加了 285%)。安非他命治疗还导致肌丝(原肌球蛋白、肌球蛋白轻链)和线粒体(ATP 合酶、NADH 脱氢酶、细胞色素 c 氧化酶、抑制素)蛋白的酪氨酸硝化。在饮用水中给予超氧化物歧化酶模拟物,tempo1 可预防安非他命引起的左心室扩张和收缩功能障碍;然而,tempo1(2.5mM)不能预防舒张功能障碍。Tempo1 显著减少,但不能消除左心室中二氢乙啶染色,也不能预防线粒体和收缩蛋白的酪氨酸硝化。
这项研究表明,氧化应激在介导安非他命引起的偏心性左心室扩张和收缩功能障碍中起重要作用。